Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$1.22 - $2.41 $8,930 - $17,641
-7,320 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$3.5 - $4.47 $11,707 - $14,952
-3,345 Reduced 31.36%
7,320 $26,000
Q3 2017

Nov 14, 2017

BUY
$3.15 - $4.01 $33,594 - $42,766
10,665
10,665 $41,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.